初探安非他命使用者接受戒癮治療之評估工具

Pilot Study on Assessment Tools for Amphetamine Users Entering Addiction Treatment

10.6550/ACP.202312_17(1_2).0004

林耿樟(Keng-Chang Lin)；蘇淑文(Shu-Wen Su)；陳沛緹(Pei-Ti Chen)；沈秉煌(Bing-Huang Shen)；徐魏謙(Wei-Chien Hsu)

安非他命使用者 ； 戒癮治療 ； 評估工具 ； amphetamine users ； addiction treatment ； assessment tools

臨床心理學刊

17卷1/2期（2023 / 12 / 01）

44 - 65

繁體中文;英文

目的：當安非他命使用者到醫院尋求戒癮治療，都需要接案評估，以利分流處遇，若能善用標準化評估工具協助配對適宜的處遇方案，將有助於提升醫療效能。本研究目的是探索安非他命使用者接受戒癮治療的評估工具，分析再測信度、哪些工具能預測復發用藥、以及哪些工具能做為療效評估之用。方法：本研究以106名門診的安非他命戒癮者為樣本，分析藥物濫用篩檢量表、藥物依賴嚴重度量表、中文版自我效能量表、貝克憂鬱量表第二版、貝克焦慮量表、巴氏衝動量表、魏氏成人智力量表的記憶廣度分測驗，以及愛荷華賭局測驗的再測信度；以二元邏輯斯迴歸分析，找出可預測藥癮復發用藥的工具；以相依樣本t檢定分析治療前後得分差異。結果：愛荷華賭局測驗的再測信度不顯著；藥物依賴嚴重度量表、貝克焦慮量表、巴氏衝動量表與記憶廣度分測驗的最長逆背可以預測有無藥癮復發用藥；藥物依賴嚴重度量表、貝克憂鬱量表第二版、貝克焦慮量表可做為成效評估工具。結論：如果評估時間短暫，可選用藥物依賴嚴重度量表、貝克焦慮量表、巴氏衝動量表與記憶廣度分測驗。而藥物依賴嚴重度量表、貝克憂鬱量表第二版、貝克焦慮量表可做為戒癮成效評估工具。未來可用戒治所或監獄等樣本重複此研究。進一步驗證巴氏衝動量表與記憶廣度分測驗是否可做為戒癮成效評估工具。

Objective: When an amphetamine user seeks addiction treatment at a hospital, we will conduct an intake assessment to facilitate subsequent diversion program. If the standardized assessment tools are fully utilized to help match drug users with appropriate treatment, it can streamline medical practice efficiency. The purpose of this study is to explore the assessment tools of amphetamine users receiving addiction treatment, to test the test-retest reliability of these assessment tools, to test which tools predicted the relapse to drug use, and to test which tools are suitable for evaluating the outcomes of addiction treatment. Methods: In this study, we researched a sample of 106 outpatient amphetamine users by analyzing the test-retest reliability of the Drug Abuse Screening Test (DAST-10), Severity of Dependence Scale (SDS), Chinese version of General Self-Efficacy Scale (C-GSE), Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), Barratt impulsiveness scale (BIS-11), and Digit Span Subscale of Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV), and Iowa Gambling Task (IGT). Binary logistic regression was used to highlight tools that effect the relapse to drug use. In addition, we analyzed score changes between pretreatment and posttreatment with paired-samples t test. Results: The test-retest reliability of the IGT is not ideal. The SDS, BAI, BIS-11, and Digit Span Subscale can effectively predict the relapse to drug use. The SDS, BDI-II, and BAI can be the indicators of addiction treatment outcomes. Conclusions: For quick assessment, we can opt for SDS, BAI, BIS-11, and Digit Span subscale. The SDS, BDI-II, and BAI can be the indicators of addiction treatment outcomes. Repeat this study with samples from drug rehabilitation centers or prison for future use cases. Further confirm that BIS-11 and Digit Span Subscale are suitable for evaluating the outcomes of addiction treatment.

1. Wang, Y. C.,Tzeng, D. S.,Li, T. C.,Lee, P. H.,Liang, C. S.(2017).Predictors of completing deferred prosecution program among methamphetamine offenders.Taiwanese Journal of Psychiatry,31(4),318-326.
   連結：
2. 何玉娟,方素真,陳辭一,高君慈,黃正誼,洪嘉均(2022)。甲基安非他命藥癮者治療預後因子分析—緩起訴二級毒品附命戒癮治療相關因素及性別差異分析研究。中華心理衛生學刊，35(2)，145-179。
   連結：
3. Bador, K.,Kerekes, N.(2020).Evaluation of an integrated intensive cognitive behavioral therapy treatment within addiction care.the Journal of Behavioral Health Services and Research,47(1),102-112.
4. Baker, A.(Ed.),Lee, N.K.(Ed.),Jenner, L.(Ed.)(2004).Models of intervention and care for psychostimulant users.Commonwealth of Australia Canberra.
5. Baker, A.,Dawe, S.(2005).Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment.Australian Psychologist,40(2),88-95.
6. Bandura, A.(1986).Social Foundations of Thought and Action: A social cognitive Theory.Prentice-Hall.
7. Bechara, A.(2007).Iowa Gambling Task Professional Manual.Psychological Assessment Resources, Inc..
8. Beck, A. T.,林真一（譯）(2000).貝克焦慮量表指導手冊中文版.中國行為科學社.
9. Beck, A. T.,陳心怡（譯）(2000).貝克憂鬱量表第二版指導手冊中文版.中國行為科學社.
10. Bernheim, A.,See, R. E.,Reichel, C. M.(2016).Chronic methamphetamine self-administration disrupts cortical control of cognition.Neuroscience & Biobehavioral Reviews,69,36-48.
11. Boness, C. L.,Watts, A. L.,Moeller, K. N.,Sher, K. J.(2021).The etiologic, theorybased, ontogenetic hierarchical framework of alcohol use disorder: A translational systematic review of reviews.Psychological Bulletin,147(10),1075-1123.
12. Brand, M.,Recknor, E. C.,Grabenhorst, F.,Bechara, A.(2007).Decisions under ambiguity and decisions under risk: Correlations with executive functions and comparisons of two different gambling tasks with implicit and explicit rules.Journal of Clinical and Experimental Neuropsycholgy,29(1),86-99.
13. Brooks, S. J.,Wiemerslage, L.,Burch, K. H.,Maiorana, S. A.,Cocolas, E.,Schiöth, H. B.,Kamaloodien, K.,Stein, D. J.(2017).The impact of cognitive training in substance use disorder: the effect of working memory training on impulse control in methamphetamine users.Psychopharmacology,234(12),1911-1921.
14. Brown, T. G.,Seraganian, P.,Tremblay, J.,Annis, H.(2002).Process and outcome changes with relapse prevention versus 12-Step aftercare programs for substance abusers.Addiction,97(6),677-689.
15. Buelow, M. T.,Barnhart, W. R.(2018).Test-retest reliability of common behavior decision making tasks.Archives of Clinical Neuropsychology,33(1),125-129.
16. Carey, K.B,Carey, M. P.,Chandra, P. S.(2003).Psychometric evaluation of the alcohol use disorders identification test and short drug abuse screening test with psychiatric patients in India.Journal Clinical Psychiatry,64(7),767-774.
17. Chang, K. C.,Chen, H. P.,Huang, S. W.,Chen, J. S.,Potenza, M. N.,Pakpour, A. H.,Lin, C. Y.(2022).Comparisons of psychological distress and self-stigma among three types of substance use disorders receiving treatment-as-usual approaches: Real-world data from a 9-month longitudinal study.Therapeutic Advances in Chronic Disease,13,20406223221140393.
18. Chen, K. W.,Lin, G. H.,Chen, N. C.,Wang, J. K.,Hsieh, C. L.(2020).Practice effects and test-retest reliability of the continuous performance test, identical pairs version in patients with schizophrenia over four serial assessments.Archives of Clinical Neuropsychology,35(5),545-552.
19. Chen, V. C. H.,Chen, H.,Lin, T. Y.,Chou, H. H.,Lai, T. J.,Ferri, C. P.,Gossop, M.(2008).Severity of heroin dependence in Taiwan: reliability and validity of the Chinese version of the Severity of Dependence Scale (SDS [Ch]).Addictive Behaviors,33(12),1590-1593.
20. Cheung, S. K.,Sun, S. Y.(1999).Assessment of optimistic self-beliefs: Further validation of the Chinese version of the general self-efficacy scale.Psychological reports,85(3_suppl),1221-1224.
21. Cocco, K. M.,Carey, K. B.(1998).Psychometric properties of the Drug Abuse Screening Test in psychiatric outpatients.Psychological Assessment,10(4),408-414.
22. Dyer, K. R.,Cruickshank, C. C.(2005).Depression and other psychological health problems among methamphetamine dependent patients in treatment: Implications for assessment and treatment outcome.Australian Psychologist,40(2),96-108.
23. Ersche, K. D.,Turton, A. J.,Pradhan, S.,Bullmore, E. T.,Robbins, T. W.(2010).Drug addiction endophenotypes: Impulsive versus sensation-seeking personality traits.Biol Psychiatry,68(8),770-773.
24. Farhad, H.,Abolghasemi, S.,Hamzehpoor, T.(2022).Effectiveness of matrix treatment on depression and temptation in consumption In amphetamine dependent individuals.Iranian Evolutionary and Educational Psychology Journal,4(4),76-83.
25. Fossati, A.,Di Ceglie, A.,Acquarini, E.,Barratt, E. S.(2001).Psychometric properties of an Italian version of the Barratt Impulsiveness Scale-11 (BIS-11) in nonclinical subjects.Journal of Clinical Psychology,57(6),815-828.
26. Gossop, M.,Best, D.,Marsden, J.,Strang, J.(1997).Test-retest reliability of the Severity of Dependence Scale.Addiction,92(3),353.
27. Gowin, J. L.,Sloan, M. E.,Ramchandani, V. A.,Paulus, M. P.,Lane, S. D.(2018).Differences in decision-making as a function of drug of choice.Pharmacology, Biochemistry, and Behavior,164,118-124.
28. Gwaltney, C. J.,Shiffman, S.,Balabanis, M. H.,Paty, J. A.(2005).Dynamic self-efficacy and outcome expectances: Prediction of smoking lapse and relapse.Journal of Abnormal Psychology,114(4),661-675.
29. He, Y.,Zhai, J.,Liu, Y.(2020).Association of methamphetamine use with depressive symptoms and gender differences in this association: A meta-analysis.Journal of Substance Use,25(4),440-448.
30. Ilgen, M.,Mckellar, J.,Moos, R.(2007).Personal and treatment-related predictions of abstinence self-efficacy.Journal of Studies on Alcohol and Drugs,68(1),126-132.
31. Jacobson, N. S.,Roberts, L. J.,Berns, S. B.,McGlinchey, J. B.(1999).Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives.Journal of Consulting and Clinical Psychology,67(3),300-307.
32. Kadden, R. M.,Litt, M. D.(2011).The role of self-efficacy in the treatment of substance use disorders.Addictive Behaviors,36(12),1120-1126.
33. Karlsen, R. H.,Karr, J. E.,Saksvik, S. B.,Lundervold, A. J.,Hjemdal, O.,Olsen, A.,Skandsen, T.(2022).Examining 3-month test-retest reliability and reliable change using the Cambridge Neuropsychological Test Automated Battery.Applied Neuropsychology: Adult,29(2),146-154.
34. Kwako, L. E.,Momenan, R.,Grodin, E. N.,Litten, R. Z.,Koob, G. F.,Goldman, D.(2017).Addictions neuroclinical assessment: A reverse translational approach.Neuropharmacology,122,254-264.
35. Kwako, L. E.,Momenan, R.,Litten, R. Z.,Koob, G. F.,Goldman, D.(2016).Addictions neuroclinical assessment: A neuroscience-based framework for addictive disorders.Biological Psychiatry,80(3),179-189.
36. Lo, A. H. Y.,Humphreys, M.,Byrne, G. J.,Pachana, N. A.(2012).Test-retest reliability and practice effects of the Wechsler Memory Scale-III.Journal of Neuropsycholgy,6(2),212-231.
37. Long, E. C.,Kaneva, R.,Vasilev, G.,Moeller, F. G.,Vassileva, J.(2020).Neurocognitive and psychiatric markers for addiction: Common vs. specific endophenotypes for heroin and amphetamine dependence.Current Topics in Medicinal Chemistry,20(7),585-597.
38. Longabaugh, R.(Ed.),Wirtz, P. W.(Ed.)(2001).Project MATCH hypotheses: Results and causal chain analyses.National Institute on Alcohol Abuse and Alcoholism.
39. Lumpkin, J. C. M.,Sheerin, C. M.(2019).Digit span sequencing as a neurocognitive screening tool in an aging, veteran population.Psychology & Neuroscience,12(2),180-190.
40. Marlatt, G. A.,George, W. H.(1984).Relapse prevention: Introduction and overview of the model.British Journal of Addiction,79(3),261-273.
41. McKetin, R.,Leung, J.,Stockings, E.,Huo, Y.,Foulds, J.,Lappin, J. M.,Cumming, C.,Arunogiri, S.,Young, J. T.,Sara, G.,Farrell, M.,Degenhardt, L.(2019).Mental health outcomes associated with of the use of amphetamine: A systematic review and meta-analysis.eClinical Medicine,16,81-97.
42. Mohamed, I. I.,Ahmad, H. E. K.,Hassaan, S. H.,Hassan, S. M.(2020).Assessment of anxiety and depression among substance use disorder patients: A case-control study.Middle East Current Psychiatry,27,22.
43. O’Brien, C. P.,Childress, A. R.,Ehrman, R.,Robbins, S. J.(1998).Conditioning factors in drug abuse: Can they explain compulsion?.Journal of Psychopharmacology,12(1),15-22.
44. Patton, J. H.,Stanford, M. S.,Barratt, E. S.(1995).Factor structure of the Barratt impulsiveness scale.Journal of Clinical Psychology,51(6),768-774.
45. Potvin, S.,Pelletier, J.,Grot, S.,Hébert, C.,Barr, A. M.,Lecomte, T.(2018).Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis.Addictive Behaviors,80,154-160.
46. Riskind, J. H.,Beck, A. T.,Brown, G.,Steer, R. A.(1987).Taking the measure of anxiety and depression. Validity of the reconstructed Hamilton scales.The Journal of Nervous and Mental Disease,175(8),474-479.
47. Rubenis, A. J.,Fitzpatrick, R. E.,Lubman, D. I.,Verdejo-Garcia, A.(2017).Working memory predicts methamphetamine hair concentration over the course of treatment: Moderating effect of impulsivity and implications for dual-systems model.Addiction Biology,24(1),145-153.
48. Skinner, H. A.(1982).The drug abuse screening test.Addictive Behaviors,7(4),363-371.
49. Smith, J. L.,Mattick, R. P.,Jamadar, S. D.,Iredale, J. M.(2014).Deficits in behavioural inhibition in substance abuse and addiction: A meta-analysis.Drug and Alcohol Dependence,145,1-33.
50. Sofuoglu, M.,DeVito, E. E.,Waters, A. J.,Carroll, K. M.(2013).Cognitive enhancement as a treatment for drug addictions.Neuropharmacology,64(1),452-463.
51. Stephens, R. S.,Wertz, J. S.,Roffman, R. A.(1993).Predictors of marijuana treatment outcomes: The role of self-efficacy.Journal of Substance Abuse,5(4),341-353.
52. Stock, A. K.,Rädle, M.,Beste, C.(2019).Methamphetamine-associated difficulties In cognitive control allocation may normalize after prolonged abstinence.Progress In Neuropsychopharmacology & Biological Psychiatry,88,41-52.
53. Topp, L.,Mattick, R. P.(1997).Choosing A cut-off on the Severity of Dependence Scale (SDS) for amphetamine users.Addiction,92(7),839-845.
54. Verdejo-Garcia, A.,Bechara, A.,Recknor, E. C.,Perez-Garcia, M.(2006).Decision-making and the Iowa Gambling Task: Ecological validity in individuals with substance dependence.Psychologica Belgica,46(1-2),55-78.
55. Verdejo-Garcia, A.,Benbrook, A.,Funderburk, F.,David, P.,Cadet, J. L.,Bolla, K. I.(2007).The differential relationship between cocaine use and marijuana use on decision -making performance over repeat testing with the Iowa Gambling Task.Drug and Alcohol Dependence,90(1),2-11.
56. Verdejo-Garcia, A.,Chong, T. T. J.,Stout, J. C.,Yücel, M.,London, E. D.(2018).Stages of dysfunctional decision-making in addiction.Pharmacology Biochemistry and Behavior,164,99-105.
57. Verdejo-García, A.,Lawrence, A. J.,Clark, L.(2008).Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies.Neuroscience & Biobehavioral Reviews,32(4),777-810.
58. Vogel, S. J.,Banks, S. J.,Cummings, J. L.,Miller, J. B.(2015).Concordance of the Montreal cognitive assessment with standard neuropsychological measures.Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring,1(3),289-294.
59. Volkow, N. D.,Wang, G. J.,Telang, F.,Fowler, J. S.,Logan, J.,Childress, A. R.,Jayne, M.,Ma, Y.,Wong, C.(2006).Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction.Journal of Neuroscience,26(24),6583-6588.
60. Xu, S.,Korczykowski, M.,Zhu, S.,Rao, H.(2013).Assessment of risk-taking and impulsive behaviors: A comparative assessment between three tasks.Social Behavior and Personality: An International Journal,41(3),477-486.
61. Zhang, J. X.,Schwarzer, R.(1995).Measuring optimistic self-beliefs: A Chinese adaptation of the General Self-Efficacy Scale.Psychologia: An International Journal of Psychology in the Orient,38(3),174-181.
62. 陳心怡,陳榮華,花茂棽(2015).魏氏成人智力量表第四版（WAIS-IV）中文版技術和解釋手冊.中國行為科學社.
63. 陳寬裕,王正華(2019).論文統計分析實務：SPSS 與 AMOS 的運用.五南.
64. 衛生福利部食品藥物管理署（2021）。110 年「藥物濫用案件暨檢驗統計資料」。https://www.fda.gov.tw/tc/site.aspx?sid=11556&r=1314114129
65. 賴擁連,蔡田木,吳慧菁(2019)。緩起訴附命戒癮治療者完成與撤銷戒癮治療之成分析。藥物濫用防治，4(3)，81-112。